Document Detail


Safety issues associated with the use of angiotensin-converting enzyme inhibitors.
MedLine Citation:
PMID:  17044798     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Authors:
Mario R Ehlers
Related Documents :
3003038 - Potent inhibition of angiotensin-converting enzyme by [des-pro3]-bradykinin or "convers...
1798438 - Evidence for thiol-dependent metallo-endopeptidase involved in degradation of luteinizi...
1683148 - Response to mental and physical stress before and during adrenoreceptor blocker and ang...
18550998 - Comparison between angiotensin-converting enzyme inhibitors and angiotensin receptor bl...
1482128 - In vitro and in vivo activities of dq-2556 and its mode of action.
7803448 - Changes in the distribution of the control of the mitochondrial oxidative phosphorylati...
Publication Detail:
Type:  Comment; Letter    
Journal Detail:
Title:  Expert opinion on drug safety     Volume:  5     ISSN:  1744-764X     ISO Abbreviation:  Expert Opin Drug Saf     Publication Date:  2006 Nov 
Date Detail:
Created Date:  2006-10-18     Completed Date:  2007-01-08     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101163027     Medline TA:  Expert Opin Drug Saf     Country:  England    
Other Details:
Languages:  eng     Pagination:  739-40     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Angiotensin-Converting Enzyme Inhibitors / adverse effects*
Humans
Chemical
Reg. No./Substance:
0/Angiotensin-Converting Enzyme Inhibitors
Comments/Corrections
Comment On:
Expert Opin Drug Saf. 2006 Sep;5(5):643-9   [PMID:  16907654 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Cross-cultural organizational behavior.
Next Document:  Osteonecrosis of the jaw: what do bisphosphonates do?